Source:http://linkedlifedata.com/resource/pubmed/id/17444956
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2007-4-20
|
pubmed:abstractText |
In Crohn's disease (CD) mucosal T-cells produce increased interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) levels and TNF-alpha antibody treatment [Infliximab (Ifx)] is effective. Osteopontin (OPN), a glycoprotein stimulating activated T-lymphocytes, may be involved in the disturbed immune-regulation but also in normal immune-homeostasis and mucosal repair, since it is expressed in many tissues and present in human milk. This study investigates plasma-OPN levels in CD patients during Ifx treatment and the in vitro effect of OPN on intestinal T cells. Thirty-seven CD patients received three Ifx doses at week 0, 2 and 6. Blood samples, colonic biopsies and clinical scores were obtained before treatment and at week 8, 26 and 52. In-vivo activated T-cell cultures were established from colonic biopsies in the presence of interleukin (IL)-2 and IL-4. The in vitro effect of OPN stimulation on T-cell IFN-gamma, TNF-alpha, and IL-10 production was measured. Plasma-OPN was increased in active CD (increased CRP-level) compared with quiescent disease (P = 0.02) and declined after three Ifx doses (P = 0.04). It was inversely correlated with in vitro T-cell IL-10 production. OPN increased CD69 and CD25 expression and enhanced T-cell IFN-gamma and TNF-alpha production in a dose-dependent fashion with higher levels in CD than in healthy controls (HC), but induced a concomitant higher IL-10 production in HC than CD. In conclusion, plasma-OPN levels are related to CD inflammation. In vitro, OPN-stimulated IL-10 production increases less in T-cell cultures from CD patients than from HC, indicating that IL-10 deficiency may be involved in the defect immune-regulation in CD, even after OPN stimulation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Inflammation Mediators,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Osteopontin,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0300-9475
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
453-60
|
pubmed:meshHeading |
pubmed-meshheading:17444956-Adolescent,
pubmed-meshheading:17444956-Adult,
pubmed-meshheading:17444956-Aged,
pubmed-meshheading:17444956-Antibodies, Monoclonal,
pubmed-meshheading:17444956-Cells, Cultured,
pubmed-meshheading:17444956-Crohn Disease,
pubmed-meshheading:17444956-Cytokines,
pubmed-meshheading:17444956-Female,
pubmed-meshheading:17444956-Humans,
pubmed-meshheading:17444956-Inflammation Mediators,
pubmed-meshheading:17444956-Interleukin-10,
pubmed-meshheading:17444956-Male,
pubmed-meshheading:17444956-Middle Aged,
pubmed-meshheading:17444956-Osteopontin,
pubmed-meshheading:17444956-T-Lymphocytes
|
pubmed:year |
2007
|
pubmed:articleTitle |
Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease.
|
pubmed:affiliation |
Gastro-Immuno Research Laboratory, Department of Medicine V, Aarhus University Hospital, Aarhus, Denmark. jorge@as.aaa.dk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|